ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,106
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Guselkumab for treating immune checkpoint inhibitor-induced psoriatic arthritis
Author(s):
K. Takeda
,
N Yanagitani
Publication date:
Journal:
Ann Rheum Dis
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
HLA-G and immune tolerance in pregnancy
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
3,106
Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study.
Authors:
Kato
Efficacité du guselkumab par rapport au sécukinumab chez les patients atteints de psoriasis en plaques modéré à sévère selon les traitements antérieurs du psoriasis : résultats de l’étude ECLIPSE
Authors:
M.P. Konstantinou
,
A Blauvelt
,
R Vender
…
FDA Application Review Guselkumab
Authors:
See all similar
Cited by
1
The use of interleukin-23 inhibitors to treat immune-related psoriasis induced by immune checkpoint inhibitors and in patients with active cancer: A case series and review of the literature
Authors:
Cynthia Fournier
,
Marcus Otho Butler
,
Maxwell Benjamin Sauder
See all cited by